A highly efficient heteroleptic ruthenium (II) complex cis-di(thiocyanato)(4,4′-dicarboxylic acid-2,2′-bipyridine)(4,4′-di-(2-(4-ditolylamine phenyl)ethenyl)-2,2′-bipyridine) ruthenium (II) (IJ-1) was synthesized and characterized, which when anchored on nanocrystalline TiO2 films exhibited high power conversion efficiency, 10.3%, and incident photon to electron conversion efficiency, 87%.
No takes yet. Share an insight, caveat, or question.
Yum et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: